Fig. 2: Genetic alteration features of CDC25 family members in pan-cancer.
From: CDC25A inhibition sensitizes melanoma cells to doxorubicin and NK cell therapy
A Survival prognosis analysis of cancers based on CDC25 methylation levels using Cox proportional hazard regression analysis. B, C Frequency and types of mutation in CDC25 family members.
